APA

Du Bois J. S., Trehu E. G., Mier J. W., Shapiro L., Epstein M., Klempner M., Dinarello C., Kappler K., Ronayne L., Rand W. & Atkins M. B. (19970331). Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Du Bois J S, Trehu E G, Mier J W, Shapiro L, Epstein M, Klempner M, Dinarello C, Kappler K, Ronayne L, Rand W and Atkins M B. 19970331. Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Du Bois J. S., Trehu E. G., Mier J. W., Shapiro L., Epstein M., Klempner M., Dinarello C., Kappler K., Ronayne L., Rand W. and Atkins M. B. (19970331). Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Du Bois J S, Trehu E G, Mier J W, Shapiro L, Epstein M, Klempner M, Dinarello C, Kappler K, Ronayne L, Rand W and Atkins M B. Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19970331.